Apixaban versus warfarin for anticoagulation after left ventricular assist device implantation: A multicenter real-world analysis

Anticoagulation is standard in patients with left ventricular assist devices (LVADs), but the optimal regimen remains uncertain. While warfarin has historically been utilized, the use of direct oral anticoagulants is increasing. Using the TriNetX Collaborative Research Network, we identified adult H...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Vien T. Truong, MD, Giorgi Chilingarashvili, MD, Avilash Mondal, MD, Timothy Raymond, MD, Si Pham, MD, Thomas O'Brien, MD, Eugene S. Chung, MD, Gregory F. Egnaczyk, MD, PhD
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2026-08-01
Edice:	JHLT Open
Témata:	left ventricular assist device HeartMate 3 warfarin direct oral anticoagulants apixaban
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2950133426000881
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!